USFDA Approves Renflexis Biosimilar to Remicade
USFDA approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders. The... Read More
FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis
The FDA has approved the biosimilar Inflectra (infliximab-dyyb) for multiple indications. Infectra is a biosimilar to Remicade (infliximab), and can be prescribed... Read More
Learning from Remsima, A Remicade biosimilar
Posted on16 Feb 2016
TagsA Remicade biosimilar, biocon's biosimilar, Biosimilar, highly similar drugs, Neupogen, Remicade biosimilar, Remsima, Zarxio
Comments0
USFDA staff recently decided that Celltrion and Pfizer’s biosimilar (Remsima) to Johnson & Johnson’s Remicade for rheumatoid arthritis was “highly similar” to... Read More